<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Effects of <z:chebi fb="0" ids="35940">protirelin</z:chebi> <z:chebi fb="1" ids="15193,50562">tartrate</z:chebi>, administered for 14 days (2 mg/day, i.m.) to 15 patients with <z:hpo ids='HP_0011009'>acute</z:hpo> cerebrovascular disease have been investigated </plain></SENT>
<SENT sid="1" pm="."><plain>The evaluation was performed by means of SPECT, at enrollment and at the end of treatment </plain></SENT>
<SENT sid="2" pm="."><plain>This evaluation was aimed at the early detection of ischemic damage and assessment of the size of the hypoperfusion area </plain></SENT>
<SENT sid="3" pm="."><plain>Treatment with <z:chebi fb="0" ids="35940">protirelin</z:chebi> <z:chebi fb="1" ids="15193,50562">tartrate</z:chebi> was well tolerated and led to definite improvement of the scintigraphic findings in about 74% of the patients </plain></SENT>
</text></document>